First Time in Human
Showing 1 - 25 of >10,000
Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)
Not yet recruiting
- Colitis, Ulcerative
- GSK4381406
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Aug 11, 2023
Healthy Volunteers Trial in Adelaide (SNP318 (A), Placebo (B))
Recruiting
- Healthy Volunteers
- SNP318 (A)
- Placebo (B)
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Mar 28, 2023
Heart Failure Trial in Cambridge (GSK3884464, Placebo)
Recruiting
- Heart Failure
- GSK3884464
- Placebo
-
Cambridge, United KingdomGSK Investigational Site
Jun 2, 2022
Pulmonary Disease, Chronic Obstructive Trial in Cambridge (GSK3923868, Matching , Monodose RS01)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Sep 26, 2022
Leishmaniasis Trial in Cambridge (GSK3494245, Placebo)
Recruiting
- Leishmaniasis
- GSK3494245
- Placebo
-
Cambridge, United KingdomGSK Investigational Site
Jul 21, 2022
Healthy Volunteers Trial in London (BGB149, Placebo)
Completed
- Healthy Volunteers
- BGB149
- Placebo
-
London, Harrow, Middlesex, United KingdomParexel Northwick Park
Mar 1, 2022
COVID-19 Trial in Cape Town (COVIDITY (SCOV1 and SCOV2) administered via needle-free intradermal injection, COVIDITY (SCOV1 and
Recruiting
- COVID-19
- COVIDITY (SCOV1 and SCOV2) administered via needle-free intradermal injection
- +5 more
-
Cape Town, Western Cape, South AfricaUniversity of Cape Town Lung Institute, Centre for TB Research I
May 30, 2022
Type 2 Diabetes Trial in Anaheim (Placebo, ECC5004)
Recruiting
- Type 2 Diabetes Mellitus
- Placebo
- ECC5004
-
Anaheim, CaliforniaEccogene Investigational Site
Dec 19, 2022
Hypertension Trial in Victor Harbor, Geelong (VB0004, Matching Placebo for VB0004)
Recruiting
- Hypertension
- VB0004
- Matching Placebo for VB0004
-
Victor Harbor, Melbourne, Australia
- +1 more
May 2, 2022
HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)
Recruiting
- HIV Infections
- VH4524184
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Jan 11, 2023
Short Bowel Syndrome, Parenteral Nutrition Associated Liver Disease Trial in Leeds (NST 6179, Placebo)
Recruiting
- Short Bowel Syndrome
- Parenteral Nutrition Associated Liver Disease
- NST 6179
- Placebo
-
Leeds, United KingdomCovance Clinical Research Unit, Ltd
May 3, 2022
COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)
Not yet recruiting
- COVID-19
- mRNA-CR-04 vaccine 10μg
- +3 more
-
San Diego, California
- +3 more
Aug 1, 2023
HIV Trial in Baltimore (GSK3732394, Placebo)
Terminated
- HIV Infections
- GSK3732394
- Placebo
-
Baltimore, MarylandGSK Investigational Site
Oct 4, 2021
HIV Trial in Baltimore (GSK3739937 (PIB), Placebo, GSK3739937 (Tablet))
Completed
- HIV Infections
- GSK3739937 (PIB)
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Sep 21, 2021
Leishmaniasis Trial in Cambridge (GSK3186899, Placebo)
Terminated
- Leishmaniasis
- GSK3186899
- Placebo
-
Cambridge, United KingdomGSK Investigational Site
Nov 8, 2021
Virus Diseases Trial in Rochester (1 µg CoV2 SAM (LNP))
Completed
- Virus Diseases
- 1 µg CoV2 SAM (LNP)
-
Rochester, New YorkGSK Investigational Site
May 16, 2022
Nonalcoholic Steatohepatitis, Osteoarthritis Trial in Adelaide (Placebo, ECC0509)
Recruiting
- Nonalcoholic Steatohepatitis
- Osteoarthritis
- Placebo
- ECC0509
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Aug 12, 2021
Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)
Not yet recruiting
- Advanced Mucosal Melanoma
- Envafolimab combined with recombinant human endostatin and first-line chemotherapy
- (no location specified)
Sep 15, 2023